Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans

ClinicalTrials.gov ID: NCT04237792

Public ClinicalTrials.gov record NCT04237792. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3/4 RANDOMIZED, DOUBLE-BLIND, DOSE-RANGING STUDY OF THE SAFETY AND EFFICACY OF DEXMEDETOMIDINE (DEX) USED WITH PROPOFOL (PRO) AS NEEDED FOR PROCEDURAL SEDATION OF PEDIATRIC SUBJECTS ≥1 MONTH TO <17 YEARS OF AGE UNDERGOING MRI SCANS

Study identification

NCT ID
NCT04237792
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
128 participants

Conditions and interventions

Conditions

Interventions

  • dexmedetomidine Drug
  • propofol Drug

Drug

Eligibility (public fields only)

Age range
1 Month to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 17, 2020
Primary completion
Nov 1, 2021
Completion
Nov 29, 2021
Last update posted
Nov 15, 2022

2020 – 2021

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Arkansas Children's Little Rock Arkansas 72202
Lucile Packard Children's Hospital, Stanford Palo Alto California 94304
University of California Davis Medical Center Sacramento California 95817
Baptist Health - Wolfson Children's Hospital Jacksonville Florida 32207
St. Mary's Medical Center West Palm Beach Florida 33407
Children's Healthcare of Atlanta-Egleston Atlanta Georgia 30322
IU Health Riley Hospital for Children Indianapolis Indiana 46202
University of Michigan, C.S. Mott Children's Hospital Ann Arbor Michigan 48109-4245
M Health Fairview University of Minnesota Medical Center - West Bank Minneapolis Minnesota 55454
Duke University Medical Center Durham North Carolina 27710
Brody School of Medicine at East Carolina University Greenville North Carolina 27834
Vidant Medical Center Greenville North Carolina 27834
University Hospitals Rainbow Babies and Children's Hospital Cleveland Ohio 44106
The Children's Hospital at OUMC Oklahoma City Oklahoma 73104
Children's Medical Center Dallas Texas 75235
Texas Children's Hospital Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04237792, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 15, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04237792 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →